Compare Arbitrum (ARB) vs Injective (INJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Arbitrum vs Injective — how do they compare? Arbitrum trades at Rp1,328 (market cap Rp8,78T, Rp638,51M 24h volume), while Injective trades at Rp78,615 (market cap Rp7,84T, Rp671,51M 24h volume). The key difference: Arbitrum and Injective are close in size by market cap, and Arbitrum's circulating supply is 6,6B ARB versus 100M INJ for Injective. Which is the better fit depends on your goals — on Pluang, investors hold Arbitrum for 63 Days and Injective for 37 Days on average.
| ARB | INJ | |
|---|---|---|
Market Cap | Rp8,78T | Rp7,84T |
Volume (24h) | Rp638,51M | Rp671,51M |
Circulating Supply | 6,6B ARB | 100M INJ |
Typical Hold Time | 63 Days | 37 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Arbitrum (ARB) is currently trading at Rp1,328 with a market cap of Rp8.76 trillion, showing bearish technical signals with 18 sell indicators versus 1 buy. The token is testing support near Rp1,321 while facing resistance at Rp1,370. Recent ecosystem development includes Pheasant Network's $2M funding round with Ethereum Foundation support for AI-powered cross-chain technology.
Overall outlook remains cautious with strong bearish momentum but potential from ecosystem growth. Key opportunities include AI integration developments, while major risks involve technical weakness and crypto market volatility. Investors should monitor support levels closely.
INJ is currently trading at Rp81,847 with a market cap of Rp8.18 trillion, showing bearish technical signals with moving averages indicating selling pressure while oscillators remain neutral. The token faces immediate resistance at Rp82,576 with support at Rp81,456. Recent on-chain data shows an average hold time of 37 days, suggesting moderate holding patterns among investors.
Overall outlook remains cautious with technical indicators favoring bearish momentum. Key opportunities include potential bounce from support levels, while major risks involve continued selling pressure and crypto market volatility. Investors should monitor network adoption metrics and exchange liquidity closely.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Arbitrum
Arbitrum is an Ethereum layer-2 scaling solution. It uses optimistic rollups to achieve its goal of improving speed, scalability and cost-efficiency on Ethereum. Arbitrum benefits from the security and compatibility of Ethereum. Another benefit is the higher throughput and lower fees compared to Ethereum. That is made possible thanks to moving most of the computation and storage load off-chain. Arbitrum’s native token is called ARB and is used for governance. Offchain Labs, the developers behind Arbitrum, announced the shift to a decentralized autonomous organization (DAO) structure — the Arbitrum DAO. ARB holders can vote on proposals that affect the features, protocol upgrades, funds allocation and election of a Security Council.
Read more on ARB →About Injective
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →
